Search for: "Abbott Products Inc"
Results 81 - 100
of 669
Sort by Relevance
|
Sort by Date
6 Jan 2022, 3:00 am
On January 21, 2022, Abbott & Kindermann, Inc. will present its 21st annual educational program in Sacramento for clients and colleagues interested in current land use, environmental, and real estate issues affecting commercial and residential development, agriculture, real estate transactions, easements, mining and the construction materials production industry. [read post]
4 Jan 2022, 3:00 am
Welcome to Abbott & Kindermann, Inc. [read post]
3 Jan 2022, 10:18 am
On January 21, 2022, Abbott & Kindermann, Inc. will present its 21st annual educational program in Sacramento for clients and colleagues interested in current land use, environmental, and real estate issues affecting commercial and residential development, agriculture, real estate transactions, easements, mining and the construction materials production industry. [read post]
3 Jan 2022, 3:00 am
On January 21, 2022, Abbott & Kindermann, Inc. will present its 21st annual educational program in Sacramento for clients and colleagues interested in current land use, environmental, and real estate issues affecting commercial and residential development, agriculture, real estate transactions, easements, mining and the construction materials production industry. [read post]
27 Dec 2021, 7:02 am
Jude Medical Inc.: $27 Million Settlement In early July, St. [read post]
23 Dec 2021, 3:00 am
On January 21, 2022, Abbott & Kindermann, Inc. will present its 21st annual educational program in Sacramento for clients and colleagues interested in current land use, environmental, and real estate issues affecting commercial and residential development, agriculture, real estate transactions, easements, mining and the construction materials production industry. [read post]
21 Dec 2021, 9:24 am
Our national product liability and mass tort firm is seeking potential Similac lawsuits against the formula manufacturer, Abbott Laboratories Inc., for failure to warn about the risks of NEC associated with Similac. [read post]
20 Dec 2021, 4:48 am
Our firm is currently looking into potential Similac lawsuits against the formula manufacturer, Abbott Laboratories Inc., for failure to warn about the risks of NEC associated with Similac. [read post]
22 Nov 2021, 3:00 am
Welcome to Abbott & Kindermann, Inc. [read post]
17 Nov 2021, 10:11 am
In January and February of 2022, Abbott & Kindermann, Inc. will present its 21st annual educational program for clients and colleagues interested in current land use, environmental, and real estate issues affecting commercial and residential development, agriculture, real estate transactions, easements, mining and the construction materials production industry. [read post]
5 Nov 2021, 11:13 am
SquareTrade Inc., 2021 WL 5113176, No. 20-cv-02725-JCS (N.D. [read post]
22 Oct 2021, 10:11 am
Over the last 12 months, numerous product liability lawsuits have been filed against the manufacturer of Similac (Abbott Laboratories, Inc.) and the maker of Enfamil (Mead Johnson Nutrition). [read post]
22 Oct 2021, 10:11 am
Over the last 12 months, numerous product liability lawsuits have been filed against the manufacturer of Similac (Abbott Laboratories, Inc.) and the maker of Enfamil (Mead Johnson Nutrition). [read post]
19 Oct 2021, 10:10 am
Abbott Lab’ys, No. 20-CV-02127, 2021 WL 428820, at *5 (N.D. [read post]
5 Oct 2021, 3:00 am
Welcome to Abbott & Kindermann, Inc. [read post]
5 Oct 2021, 3:00 am
Welcome to Abbott & Kindermann, Inc. [read post]
17 Sep 2021, 4:00 am
National/Federal Delta Variant Postpones K Street’s Full Return MSN – Kate Ackley (Roll Call) | Published: 9/14/2021 On the cusp of Memorial Day back in May, most lobbyists were gearing up for a more normal return to their in-person work life, as they began to reemerge for meetings on Capitol Hill and sessions with clients and colleagues. [read post]
1 Sep 2021, 3:00 am
Welcome to Abbott & Kindermann, Inc. [read post]
1 Sep 2021, 3:00 am
Welcome to Abbott & Kindermann, Inc. [read post]
23 Aug 2021, 2:12 am
Congress, to exercise March-in rights for patents owned by Abbott laboratories, Inc. [read post]
